Ebola Patient Dies in Nebraska

The video covers several major topics: Allergan's acquisition by Activists, ending a hostile takeover bid by Valeant Pharmaceuticals, and the potential for more deals in the biotech and pharma sectors. Halliburton's acquisition of Baker Hughes is discussed, highlighting the impact of low oil prices and regulatory considerations. Japan's economic recession is examined, attributed to a recent tax hike. Lastly, the video reports on the death of an Ebola patient, Martin Saliou, who was treated in the US after being transported from Sierra Leone.

What was the nature of the deal involving Allergan?

What are some potential areas of investment for big pharmaceutical companies?

How much was Halliburton's deal with Baker Hughes worth?

What impact did the tax hike in April have on Japan's economy?

What was the outcome of the Ebola patient's treatment?